SUMMARY
Inflammation triggers the differentiation of Ly6C hi monocytes into microbicidal macrophages or monocyte-derived dendritic cells (moDCs). Yet, it is unclear whether environmental inflammatory cues control the polarization of monocytes toward each of these fates or whether specialized monocyte progenitor subsets exist before inflammation. Here, we have shown that naive monocytes are phenotypically heterogeneous and contain an NR4A1-and Flt3L-independent, CCR2-dependent, + moDCs but generated iNOS + macrophages more efficiently. Therefore, intercellular disparities of PU.1 expression within naive monocytes segregate progenitor activity for inflammatory iNOS + macrophages or moDCs.
INTRODUCTION
Haematopoietic stem cells continually give rise to mononuclear phagocytes, including monocytes and conventional dendritic cells (DCs) (Steinman and Cohn, 1973) . Both monocytes and DCs arise from common early bone marrow (BM) myeloid progenitors called MDPs (Fogg et al., 2006; Lee et al., 2015) . MDPs further differentiate into (1) monocyte-committed progenitors (cMoPs) (Hettinger et al., 2013) , giving rise to Ly6C + monocytes unable to differentiate into DCs, and (2) common DC progenitors (CDPs) Naik et al., 2007; Onai et al., 2007) , which do not give rise to monocytes but generate circulating precursors for DCs (pre-DCs) Liu et al., 2009 ). More recently, MDPs have been shown to generate granulocytes as well (Sathe et al., 2014) . Initially defined by their ability to drive the priming of naive T cells after activation (Nussenzweig et al., 1980) , DCs are now regarded as a specific hematopoietic lineage defined by their dependency on growth factor Flt3L , which engages the Flt3 receptor tyrosine kinase (CD135) (Waskow et al., 2008) , and the expression of the transcription factor (TF) ZBTB46 . Fate-mapping (Schraml et al., 2013) and barcoding (Naik et al., 2013) studies have firmly established that DCs are distinct from other lineages.
Monocytes are BM-derived mononuclear phagocytes that circulate in the blood stream. In mice, circulating monocytes are classically defined by expression of CD115 (CSF1R), a receptor for the macrophage growth factor CSF1 (M-CSF). Two categories of monocytes have been identified on the basis of Abs. no. Abs. no.
Flt3l
Flt3l (Geissmann et al., 2003) . Various studies support the notion that Ly6C + monocytes can convert to blood Ly6C À monocytes (Hettinger et al., 2013; Sunderkö tter et al., 2004; Varol et al., 2007; Yona et al., 2013) . However, selective impairment of Ly6C + monocytes in Irf8 À/À mutant mice suggests an independent developmental pathway for Ly6C À monocytes (Kurotaki et al., 2013) . The egress of BM Ly6C + monocytes at steady state requires the engagement of the chemokine receptor CCR2 (Serbina and Pamer, 2006) . By contrast, most Ly6C À monocytes gain access to the bloodstream independently of CCR2 and rely on the TF NR4A1 (Hanna et al., 2012) . They exhibit a ''patrolling'' behavior (Auffray et al., 2007) and scavenge damaged endothelia during inflammation (Carlin et al., 2013) . A subset of Ly6C À monocytes expressing extracellular major histocompatibility complex II (MHCII) has also been described (Jakubzick et al., 2013 (Serbina et al., 2003) . iNOS + Ly6C + phagocytes are distinct from the DC lineage 
and are essential for the control of Listeria infection, as demonstrated by infection of Nos2
À/À (MacMicking et al., 1995) , Ccr2 À/À (Serbina et al., 2003) , and monocyte-depleted (Schreiber et al., 2013) mice. In addition to differentiating into iNOS + phagocytes, Ly6C + monocytes can differentiate into CCR2-dependent monocytederived DCs (moDCs) (Bain et al., 2013; Zigmond et al., 2012) . Accordingly, moDCs can be generated upon adoptive transfer of Ly6C + monocytes that progressively lose Ly6C and acquire MHCII when differentiating in inflamed tissues (Bain et al., 2013; Zigmond et al., 2012) . FcgRI (CD64), FcεRI, and CD206 have emerged as markers of inflammatory phagocytes distinct from the DC lineage (Cheong et al., 2010; Langlet et al., 2012; Plantinga et al., 2013) .
The processes regulating the polarization of Ly6C + monocytes toward iNOS + macrophages or moDCs remain unclear. Local inflammatory cues might control the nature of monocyte progeny. Alternatively, monocyte subpopulations might be endowed with a selective potential to generate iNOS + phagocytes or moDCs. Here, we report the description and functional characterization of monocyte subsets endowed with the selective ability to generate iNOS + phagocytes or moDCs. We show that the amount of PU.1 arbitrates the commitment of monocytes toward either cell fate.
RESULTS

Ly6C + Monocytes Are Heterogeneous
As an initial approach to addressing the heterogeneity of BM mononuclear phagocyte precursors, we analyzed the expression of CD135 (Flt3) and CD115 (CSF1R) in Lin À BM cells (Figure 1A ; isotype controls in Figure S1A ). MHCII + cells were not considered because they correspond to F4/80 hi BM macrophages ( Figure S1B Figure 1A ) and was distinct from cKit + CD115 + Flt3 + CDPs (Naik et al., 2007; Onai et al., 2007 ; Figure S1D ).
Within pre-DCs, R3 coexisted with CD115 À pre-DCs (P) and aligned with both the Ly6C + SiglecH À and Ly6C + SiglecH + pre-DC subsets ( Figure 1A ; Schlitzer et al., 2015) . R1 and R2 monocytes expressed heterogeneous amounts of CD11b and CX3CR1 ( Figure S1E ), had horse-shoe-shaped nuclei (Figure S1F) , and were distinct from Nr4a1-dependent Ly6C lo monocytes ( Figure S1G ).
Blood Lin À CD115 + Ly6C + cells, like their Ly6C + BM counterparts, also contained sub-populations R1-R3 (Figures 1B and 1C) . R1 expressed higher amounts of CCR2 than R2 and R3 (Figure S1E) , and Ccr2 inactivation drastically restricted the size of circulating R1 and R2 monocytes, but not pre-DCs ( Figure S1H ). Mixed BM chimeras of wild-type (WT) and Ccr2 À/À cells showed that CCR2 controls the egress of R1 and R2 monocytes by a cell-intrinsic effect ( Figures 1B and S1I ). Unlike pre-DCs and DCs , BM and blood R1 and R2 cells were largely independent of growth factor Flt3L ( Figure 1C ). The DC-specific TF-encoding gene Zbtb46 (BTBD4) was highly expressed only in R3 and P pre-DCs ( Figure 1D ). Accordingly, reporter expression in Zbtb46 GFP/+ mice and fate mapping in the Zbtb46 Cre x Rosa lslYFP model (Loschko et al., 2016; Figures 1E and S1J) showed that splenic R3 and P preDCs, but not R1 or R2 monocytes, belonged to the DC lineage. Genes with higher expression in R3 pre-DCs than in R2 monocytes largely overlapped the genes with higher expression in R3 pre-DCs than in R1 monocytes (e.g., Clec9a and Slamf7; Figure 1F, red dots; Table S1 ) and, to a lesser extent, overlapped genes with higher expression in R2 monocytes than in R1 monocytes (Ctsg and Flt3; Figure 1F , red dots in lower left plot). R3 (C) (F) Genes differentially expressed among R1-R3. Volcano plots of R2 versus R3 (main plot) show genes with a fold change R 2 and a p value of p < 0.05 in R2 (blue) and R3 (red). These genes are overlaid on volcano plots of R1 versus R2 (left) and R1 versus R3 (right) with the same axes of fold change and p value. Numbers indicate differentially expressed genes in each comparison (gene list available in Table S1 ).
(G) Clustering of R1-R3 with pre-DCs and CDPs. Principal-component analysis compares microarray data of R1 (blue), R2 (red), and R3 (green) with previously published data of pre-DCs (yellow) and CDPs (violet) on PC1 (72% variance), PC2 (24% variance), and PC3 (2% variance).
(H) Hierarchical clustering analysis (1 À Pearson correlation) of monocytes (R1 and R2), pre-DCs (R3), total pre-DCs, and CDPs. Data represent the mean ± SEM (*p < 0.05;**p < 0.005; ns, not significant; Student's t test). Please also refer to Figure S1 . pre-DCs expressed genes belonging to the DC signature (Miller et al., 2012) (e.g., Clec9a and Slamf7; Figures 1F and S1K) and clustered with total pre-DCs and CDPs (Figures 1G and 1H) . Genes with higher expression in R2 monocytes than in R3 preDCs ( Figure 1F , blue dots in the main panel) largely overlapped the genes with higher expression in R1 monocytes than in R3 pre-DCs (e.g., Msr1 and Fcgr3; Figure 1F , lower right plot; Table S1 ). However, most of these genes were not differentially expressed between R2 and R1 monocytes ( Figure 1F , blue dots in lower left panel). Furthermore, R1 and R2 expressed a macrophage signature (e.g., Fcgr3 and Csf3r; Figure S1K ; Gautier et al., 2012) while clustering close to each other ( Figures 1G  and 1H ) apart from the DC-committed precursors.
Overall, R1 and R2 were more similar to each other than to R3 (Figures 1F-1H ; Table S1 ). We conclude that R1 and R2 qualify as bona fide monocytes given that both are largely CCR2 dependent for BM egress, do not rely on Flt3L, and do not express Zbtb46. R3 met all the criteria for bona fide pre-DCs because it was largely CCR2 independent and Flt3L dependent and expressed the DC-specific Zbtb46 .
R2 Monocytes Bear a Mixed Transcriptional Profile
We next aimed to assess the diversity of Ly6C + monocytes by using unsupervised analyses. To this end, we used multi-dimensional reduction analysis of multi-parametric flow cytometry. BM Ly6C + CD115 + cells were divisible into one major Flt3 À and three minor Flt3 + subsets with distinct t-distributed stochastic neighbor embedding (t-SNE) coordinates (populations A-C) ( Figure 2A ). Population A was CD11c À and found only within R2. By contrast, populations B and C overlapped R2 and R3. Unlike population C, A and B phenotypically shared high expression of FcgRII and/or FcgRIII with R1 monocytes. However, like population C but unlike R1 monocytes, A and B expressed CD209a ( Figure 2B ). All together, these data were corroborated by microarray analysis of BM R1-R3 populations ( Figure S2A ) and flow cytometry analysis of blood Ly6C + cells ( Figure S2B ). In addition, population C had lower CD11b expression than A and B ( Figure 2B ).
As a parallel unsupervised approach, we used gene-expression profiling at the single-cell level to assess the diversity of Ly6C + CD115 + cells. We performed single-cell qPCR by using a set of 42 genes and 3 house-keeping controls. Unsupervised clustering of gene expression at the single-cell level revealed the existence of five clusters within Ly6C + CD115 + cells (Figure 2C) . Clusters 1 and 2 aligned mostly with R1 and also partially with R2. Cluster 3 was exclusively represented within R2, whereas clusters 4 and 5 were enriched in R3 but also present in R2 ( Figures 2C-2E ). Cluster 3 was unique in its mixed expression pattern of monocyte (Fcgr3, Fcgr2b, and Csf3r) and DC (Kmo, Cd209a, and Flt3) genes (Figures 2C and 2F and S2A and S2B) . However, cluster 3 (in addition to clusters 1 and 2) showed low transcription of Zbtb46, which was found in clusters 4 and 5 ( Figure 2F ). Of interest, we noticed that the expression of Ciita and MHCIIrelated genes was found mostly in clusters 3 and 5 ( Figure S2C ). This is consistent with MHCII expression in BM and blood R2 and R3, as assessed by flow cytometry and microarray analysis (Figures S2D and S2E ). R2 and R3 thus aligned with previously described Ly6C + CD115 + MHCII + cells in the blood (Carlin et al., 2013; Jakubzick et al., 2013; Figure S2F (Carotta et al., 2010) and MHCII through the induction of Ciita (Bakri et al., 2005) . Intracellular flow cytometry staining for PU.1 indicated that R3 pre-DCs and R2 monocytes expressed higher amounts of PU.1 than R1 monocytes ( Figure 3A) . Accordingly, PU.1 was expressed more in MHCII + than in MHCII À blood CD115 + cells ( Figure 3B ). Please also refer to Figure S2 .
pre-DCs, R1 monocytes were slightly increased in the BM of Sfpi1 +/À mice ( Figure 3E ). However, this increase did not reach significance in the blood ( Figures 3E, S3A , and S3B). Sfpi1 hemizygosity reduced the numbers of MDPs and CDPs, but not cMoPs ( Figure S3F (Serbina et al., 2003) . In agreement with their independence of Flt3L (Loschko et al., 2016) , thus confirming their monocytic origin ( Figure S4A remained mostly MHCII lo ( Figure 4A ), unless these cells were treated with interferon-g (IFN-g), which increased MHCII expression in iNOS + cells ( Figure S4B ). Figure 4C ). Transcriptomic analysis of BM R1-R3 demonstrated an upregulation of toll-like receptor (TLR) signaling, RIG-like helicase, NOD-like receptor genes, and IFN-g signaling and its target genes in R1 monocytes ( Figure 4D ). We conclude that R1 cells are efficiently equipped for innate sensing prior to microbial exposure.
We next wanted to determine whether iNOS + macrophages lose iNOS and enter a differentiation pathway of monocytes characterized by the loss of Ly6C in inflamed tissues (Bain et al., 2013; Zigmond et al., 2012 Normalized Abs no. Figure 7C ). Control populations such as B cells and granulocytes were generated as efficiently upon transfer of either Sfpi1 +/+ or Sfpi1 +/À BM ( Figure S7B ). We conclude that PU.1 selectively controls the differentiation of GM-CSF-dependent CD209a
MHCII
+ moDCs by a cell-intrinsic mechanism.
DISCUSSION
Depending on the study, monocyte-derived inflammatory cells (distinct from the cDC lineage) are termed inflammatory macrophages (Bain et al., 2013; Tamoutounour et al., 2012) or moDCs (Cheong et al., 2010; Plantinga et al., 2013; Zigmond et al., 2012) . Here, we report that distinct monocyte subsets give rise to iNOS + inflammatory macrophages and CD209a + moDCs. with previously described cDC2-commited pre-cDCs (preDC2s) (Schlitzer et al., 2015; are diverse in terms of MHCII or CD209a expression, for example. The functional relevance of pre-DC2 heterogeneity for the generation of multiple cDC2 subsets (Lewis et al., 2011; remains to be addressed. An important question that arises is the transcriptional mechanism driving the steady-state differentiation of Ly6C + monocytes into a small sub-population with a distinct potential to generate moDCs or inflammatory macrophages. PU.1 is a lineage-determining TF essential for hematopoietic stem cells and has multiple roles in the myeloid lineage (Dakic et al., 2005; DeKoter and Singh, 2000; Scott et al., 1994) . PU.1 cooperates with multiple other TFs to shape the enhancer landscape of tissue-resident macrophages (Lavin et al., 2014; Norris et al., 2014) . Here, we report that Sfpi1 haploinsufficiency promotes the generation of iNOS + macrophages during L.m. infection. PU.1-dependent negative regulation of iNOS + macrophages might constitute a regulatory mechanism limiting iNOS-dependent immunopathology. How does PU.1 downregulate the production of iNOS? PU.1 is known to upregulate multiple miRNAs, including miR-146 and miR-155, which in turn negatively regulate innate sensing through the regulation of TRAF6, IRAK4, and STAT1, for example (Ghani et al., 2011; Jurkin et al., 2010) . Indeed, Ly6C + monocytes from mir146 À/À mice are hyper-responsive to microbial stimulation (Etzrodt et al., 2012) . Higher amounts of PU.1 might be needed to induce mir146 and limit anti-microbial responses. Further experiments are needed to assess the relevance of miRNAs downstream of PU.1-dependent regulation of innate sensing.
We have found that, in addition to having a regulatory effect on microbicidal iNOS + macrophages, the highest amounts of PU.1 selectively promote the generation of GM-CSF-dependent moDCs in vitro and in vivo. This could be explained by (1) the reduction of moDC precursors (MHCII + R2 monocytes) in naive Sfpi1 +/À mice and (2) an effect on moDC terminal differentiation. In support of the latter, overexpression of PU.1 promotes the differentiation of DC-like cells (Bakri et al., 2005) , and inducible ablation of Sfpi1 prevents the differentiation of DCs (Carotta et al., 2010) . In this context, PU.1 cooperation with TFs IRF4 and IRF8 could be relevant to explain the role of PU.1 in moDC differentiation from monocytes. PU.1 can bind to Ets binding sites on its own, but PU.1 also cooperates with IRF4 or IRF8 at Ets-IRF composite response elements called EICEs (Brass et al., 1999) . IRF4 is known to be involved in the control of CIITA promoter pI in GM-CSF moDCs or CD11b + DCs (Gao et al., 2013; Tamura et al., 2005; Vander Lugt et al., 2014) . In addition, PU.1 might boost the expression of growth factor receptors required for the development of moDCs (e.g., CSFR2A; DeKoter et al., 1998).
In conclusion, our results shed light on the readiness of inflammatory monocyte subsets for distinct and specialized developmental programs activated in inflammatory conditions. Importantly, PU.1 amounts segregate the transcriptional programs of microbicidal iNOS + macrophages or moDCs.
EXPERIMENTAL PROCEDURES Mice
All mice used were between 6 and 12 weeks old and were matched for age and sex in all experiments. They were maintained under specific-pathogen-free conditions in accordance with the UK Animals (Scientific Procedures) Act of 1986.
Cell Isolation and Fluorescence-Activated Cell Sorting
For preparation of BM cell suspensions, the bones of both hind limbs (two tibia and two femurs) were flushed with ice-cold fluorescence-activated cell sorting (FACS) buffer (PBS (Life technologies) with 1% BSA (Apollo Scientific Ltd) and 2 mM EDTA (Life Technologies). Spleens were collected, cut into small pieces, and incubated with collagenase D (Roche) and DNaseI (Roche) in Hank's balanced salt solution (GE Healthcare) and 5% fetal bovine serum (Life technologies) for 20 min; they were further macerated through 100 mm cell strainers (BD Falcon). Red blood cells were lysed with 2 ml of Ack lysis buffer (Life Technologies), incubated for 2 min at room temperature, and then diluted with FACS buffer. After centrifugation, cells were either re-suspended in an antibody cocktail in FACS buffer or permeabilized and fixed for intracellular staining and analyzed by flow cytometry with FlowJo software (TreeStar). For cell sorting, see Supplemental Experimental Procedures.
In Vitro GM-CSF Cultures Total BM or 10 4 sorted Ly6C hi CD115 + monocytes (total or subsets R1-R3)
were cultured in 20 ng/ml of GM-CSF in complete RPMI with 6,000 live MS-5 cells as ''feeders,'' which were plated on the same day. Analyzed cells were pre-gated to be DAPI À and CD45 + .
In Vitro L.m. Infections Primary cells infected with L.m. were in vivo cultured overnight at an MOI of 0.01, 0.1, 1, or 10 (as indicated in Figure 5 ) in complete RPMI medium supplemented with macrophage colony-stimulating factor (MCSF, 20 ng/ml; Peprotech), GM-CSF (3 ng/ml; Peprotech), and human Flt3L (100 ng/ml; CellDex). BMDMs were derived by culture of whole BM in RPMI supplemented with culture medium from L-929 cells.
B16-GM-CSF Tumor Experiments
B16-GM-CSF tumor cells were checked for viability with Trypan Blue, and 1.5 3 10 5 to 3 3 10 5 live cells were injected subcutaneously (see Supplemental Experimental Procedures). 
t-SNE Analysis
Single-cell analysis using the t-SNE algorithm was done on flow cytometry data in the online platform provided by Cytobank (see Supplemental Experimental Procedures).
Single-Cell qPCR
Single cells were sorted by flow cytometry, cDNA was amplified with the CellsDirect One-Step qRT-PCR Kit (ThermoFisher), and qPCR was run on a BioMark HD (Fluidigm) with the help of Taqman probes (Life Technologies) for the genes indicated in Figure 2 . The 45 targeted genes were analyzed against an average of three housekeeping genes: Hprt, ActB, and Gapdh. Analysis was done with the help of Gene-E software (Broad Institute) (see Supplemental Experimental Procedures). 
Statistical Analysis
Data were analyzed for statistical significance by unpaired Student's t tests. Differences were considered significant at p < 0.05 (*p < 0.05; **p < 0.005; ***p < 0.0005; ****p < 0.00005; ns, non-significant).
ACCESSION NUMBERS
The accession number for the microarray data reported in this paper is GEO: GSE90471. 
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Supplemental Experimental Procedures
Mice: C57Bl/6 mice were bought from Charles River Laboratories, UK. Ccr2 -/- (Boring et al., 1997) , Nr4a1 -/- (Lee et al., 1995) , Sfpi1 +/- (Bechade et al., 2014) was injected intravenously at a dose of 5 x 10 6 cells in100ul into these irradiated recipients. To allow full reconstitution, the mice were used at 8-16 weeks after 
Cell sorting by flow cytometry
For sorting, bone marrow or spleen cells were resuspended to an approximate concentration of 7000cells/ul. They were then sorted on a BD FACS Aria (special order machine) fitted with 405nm, 488nm, 561nm, 633nm lasers and sorted through 100um nozzle with 4-way purity. Purity checks were run on samples used for microarrays and were used when purity was found to be >95%. Both instruments were housed at the Biomedical Research Centre 
B16-GMCSF tumor experiments:
Melanoma cell lines B16 and B16 expressing GMCSF (B16-GMCSF) were maintained in RPMI1640 medium supplemented with Glutamax (Life technologies), 10% fetal bovine serum (Life technologies), 1%
penicillin-streptomycin (Life Techonologies) and 50uM beta-mercaptoethanol (Sigma) and used from between passages 4 and 10. Cells were checked for viability with Trypan Blue and 1.5-3 x 10 5 live cells were injected subcutaneously in sterile RPMI 1640 medium alone. were grown and sub-cultured in brain heart infusion broth at 37 0 C until an OD600 value of 0.12-0.15 was obtained to use bacteria in their exponential growth phase. 4 -5 x 10 3 wild type CFU (Listeria) or 10 6 ΔActA mutant CFU of Listeria monocytogenes were injected intravenously in sterile PBS.
Microarray processing and analysis:
Affymetrix CEL files were converted into gct files using the ExpressionFileCreator Module within Gene Pattern Software (Broad Institute) (Reich et al., 2006) . The RMA algorithm withquantile normalization and background correction was used. No thresholds or filters were applied for assessing the relative expression of all genes assayed on the microarray. Heat maps were generated with this data on Gene-E software.
To create the Volcano plots, Mutiplot Preprocess Module within the Gene Pattern Software (Broad Institute) was used to derive fold change and p-values from the expression dataset of the aforementioned microarrays to be used in the MultiplotVisualizer Module. This latter module was used to highlight the genes more highly expressed in R2 or R3 above a threshold of p-value set at 0.05 and fold change of 1.2. These selected genes were then overlaid on comparisons done between R1 and R2, and R1 and R3 to obtain the plots shown in Fig.1F .
PCA analysis and hierarchical clustering:
Microarray data of R1, R2 and R3 were compared with ST1.0 array data available on ImmGEN for Pre-DCs (GSE68590) ) (and CDP (GSE 15907) (www.immgen.org) on Qlucore Omics
Explorer (Sweden) and plotted as 2D plots on Prism (Graphpad). Hierarchical clustering of data sets was performed using Gene-E software (Broad Institute).
qPCR Primers: Cells were sorted as described and centrifuged. Supernatant was removed and cells were resuspended in RLT buffer from the RNeasy kit (Qiagen). mRNA was extracted using the columns as per manufacturer's instructions. mRNA was resuspended in RNase-free water and the concentration and quality measured by nanodrop (Thermo Scientific). Equal amounts of mRNA (between 0.1ng -5ug) from each sample were taken to produce cDNA using the manufacturer's First Strand cDNA synthesis protocol with the 
